SM
GILD icon

STF Management’s Gilead Sciences GILD Stock Holding History

STF Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$876K Sell
7,133
-11,745
-62% -$1.43M 0.82% 27
2025
Q3 		$2.1M Sell
18,878
-487
-3% -$55.4K 0.78% 30
2025
Q2 		$2.15M Buy
19,365
+498
+3% +$53K 0.85% 26
2025
Q1 		$2.11M Sell
18,867
-4
-0% -$413 1.01% 25
2024
Q4 		$1.74M Buy
18,871
+656
+4% +$59.1K 0.78% 29
2024
Q3 		$1.53M Sell
18,215
-1,603
-8% -$122K 0.69% 36
2024
Q2 		$1.36M Sell
19,818
-941
-5% -$62.8K 0.57% 42
2024
Q1 		$1.52M Sell
20,759
-315
-1% -$24.2K 0.66% 37
2023
Q4 		$1.71M Buy
21,074
+686
+3% +$53.4K 0.8% 30
2023
Q3 		$1.53M Buy
20,388
+12,438
+156% +$957K 0.81% 30
2023
Q2 		$613K Sell
7,950
-6,441
-45% -$514K 0.66% 29
2023
Q1 		$1.19M Buy
14,391
+6,042
+72% +$500K 0.8% 25
2022
Q4 		$717K Buy
+8,349
New +$661K 1.03% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

STF Management's GILD Position: Q4 2025 in Review

STF Management reduced its Gilead Sciences (GILD) stake by 62% in Q4 2025, selling an estimated $1.43M and leaving 7,133 shares worth $876K. The position accounts for 0.82% of the portfolio, ranked #27.

STF Management first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.15M in Q2 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • STF Management held 7,133 shares of Gilead Sciences worth $876K as of Q4 2025.
  • STF Management sold 11,745 Gilead Sciences shares in Q4 2025, an estimated $1.43M.
  • Gilead Sciences made up 0.82% of STF Management's portfolio in Q4 2025, its #27 holding.
  • STF Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • STF Management's Gilead Sciences position peaked at $2.15M in Q2 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on STF Management's 13F filing for Q4 2025, filed 5 Feb 2026.